| HER2-Low Breast Cancer: Molecular Characteristics and Prognosis E Agostinetto, M Rediti, D Fimereli, V Debien, M Piccart, P Aftimos, ... Cancers 13 (11), 2824, 2021 | 134 | 2021 |
| Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases S Le Pennec, T Konopka, D Gacquer, D Fimereli, M Tarabichi, G Tomás, ... Endocrine-related cancer 22 (2), 205-216, 2015 | 42 | 2015 |
| miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers M Saiselet, JM Pita, A Augenlicht, G Dom, M Tarabichi, D Fimereli, ... Oncotarget 7 (32), 52475, 2016 | 37 | 2016 |
| CW-PRED: a HMM-based method for the classification of cell wall-anchored proteins of Gram-positive bacteria DK Fimereli, KD Tsirigos, ZI Litou, TD Liakopoulos, PG Bagos, ... Hellenic Conference on Artificial Intelligence, 285-290, 2012 | 31 | 2012 |
| Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome D Venet, D Fimereli, F Rothé, B Boeckx, M Maetens, S Majjaj, G Rouas, ... EBioMedicine 56, 2020 | 29 | 2020 |
| G enomic hotspots but few recurrent fusion genes in breast cancer D Fimereli, D Fumagalli, D Brown, D Gacquer, F Rothé, R Salgado, ... Genes, Chromosomes and Cancer 57 (7), 331-338, 2018 | 22 | 2018 |
| No significant viral transcription detected in whole breast cancer transcriptomes D Fimereli, D Gacquer, D Fumagalli, R Salgado, F Rothé, D Larsimont, ... BMC cancer 15 (1), 1-9, 2015 | 17 | 2015 |
| TriageTools: tools for partitioning and prioritizing analysis of high-throughput sequencing data D Fimereli, V Detours, T Konopka Nucleic acids research 41 (7), e86-e86, 2013 | 16 | 2013 |
| Artificial intelligence: Theories and applications DK Fimereli, KD Tsirigos, ZI Litou, TD Liakopoulos, PG Bagos, ... CW-PRED: A HMM-Based Method for the Classification of Cell Wall-Anchored …, 2012 | 7 | 2012 |
| Timing evolution of lobular breast cancer through phylogenetic analysis D Fimereli, D Venet, M Rediti, B Boeckx, M Maetens, S Majjaj, G Rouas, ... Ebiomedicine 82, 2022 | 5 | 2022 |
| HER2-low breast cancer: molecular characteristics and prognosis. Cancers (Basel). 2021 E Agostinetto, M Rediti, D Fimereli, V Debien, M Piccart, P Aftimos | 3 | |
| Characterization of the immune microenvironment in matched primary and metastatic breast cancer lesions from the AURORA study: BIG 14-01. F Hilbers, D Venet, E Agostinetto, M Benelli, A Guerrero, ... Journal of Clinical Oncology 41 (16_suppl), 1009-1009, 2023 | 1 | 2023 |
| Integrating spatial and single cell transcriptomics to identify and characterize biologically driven subgroups in invasive lobular carcinoma M Serra, A Papagiannis, M Rediti, F Lifrange, N Occelli, L Collet, ... European Journal of Cancer 200, 2024 | | 2024 |
| Unravelling tumor heterogeneity in patients with HER2-low hormone receptor-positive breast cancer using spatial transcriptomics D Fimereli, M Serra, M Rediti, F Lifrange, N Occelli, L Collet, D Vincent, ... European Journal of Cancer 200, 2024 | | 2024 |
| Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer I Assaf, D Fimereli, G Anthoine, R Fazio, V Daprà, A Audisio, A Bardiaux, ... Cancers 15 (24), 5823, 2023 | | 2023 |
| Unravelling spatial tumor organization and heterogeneity in lobular breast cancer using spatial transcriptomics L Collet, M Serra, M Rediti, F Lifrange, D Venet, XX Wang, D Vincent, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Integrating spatial transcriptomics and high-resolution morphological annotation to investigate tumor heterogeneity and PAM50 molecular subtyping in lobular breast cancer M Serra, L Collet, M Rediti, F Lifrange, D Venet, X Wang, D Vincent, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract PD14-05: Portraying tumor evolution of lobular breast cancer through phylogenetic analysis D Fimereli, D Venet, M Rediti, DN Brown, B Boeckx, M Maetens, S Majjaj, ... Cancer Research 82 (4_Supplement), PD14-05-PD14-05, 2022 | | 2022 |
| Abstract P1-05-03: Integrating spatial transcriptomics and high-resolution morphological annotation to investigate tumor heterogeneity and PAM50 molecular subtyping in lobular … M Serra, L Collet, M Rediti, F Lifrange, D Venet, X Wang, D Vincent, ... Cancer Research 82 (4_Supplement), P1-05-03-P1-05-03, 2022 | | 2022 |
| Abstract PD14-02: Unravelling spatial tumor organization and heterogeneity in lobular breast cancer using spatial transcriptomics L Collet, M Serra, M Rediti, F Lifrange, D Venet, XX Wang, D Vincent, ... Cancer Research 82 (4_Supplement), PD14-02-PD14-02, 2022 | | 2022 |
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
